Brandes Jan Lewis
Nashville Neuroscience Group, Nashville, TN, USA.
Continuum (Minneap Minn). 2012 Aug;18(4):835-52. doi: 10.1212/01.CON.0000418646.70149.71.
This article discusses hormonal milestones and the influence that hormonal fluctuations make in the frequency and severity of migraine in women and includes information on acute, short-term, and preventive strategies for hormonally influenced migraine and the situations in which hormonal therapies may be offered.
Genomic patterns in adolescent girls differentiate between menstrually related migraine and non-menstrually related migraine. The age at initiation of estrogen replacement therapy appears to be significant with respect to stroke. No increase in stroke occurred in women on low-dose (50 µg or less) transdermal estrogen replacement compared to women not using estrogen replacement. Childhood maltreatment is more common in women with migraine and depression than in women with migraine alone.
Management of hormonally influenced migraine involves a clear identification of the relationship between migraine and hormone change. A thorough history and detailed diary are critical in identifying this relationship and in predicting response or following response to hormonal therapies. The evolution of migraine in an individual may be strongly driven by hormonal shifts. Although limited, clinical evidence suggests that oral contraceptive use in young women with episodic migraine may transform their pattern into chronic migraine. Thus, particular attention to changes in migraine patterns following either endogenous or exogenous hormonal changes is crucial. Providing reassurance and education that migraine is a biological disorder and providing an understanding of the role of estrogen in the frequency and severity of migraine can guide treatment choices. Pharmacologic treatments include acute therapy, with short-term and standard prevention offered where appropriate. Hormonal therapies are not first-line therapies but may be important choices for a woman with migraine whose estrogen fluctuation is continually exacerbating migraine attacks. Given the many hormonal stages during the life of a woman with migraine, therapies may vary according to hormonal stage and status. Overall wellness should also be emphasized; regular exercise, balanced diet, smoking cessation, weight control, and sleep hygiene are important in the management of migraine.
本文讨论了激素里程碑事件以及激素波动对女性偏头痛发作频率和严重程度的影响,并介绍了针对激素性偏头痛的急性、短期和预防性治疗策略,以及在哪些情况下可提供激素治疗。
青春期女孩的基因组模式可区分与月经相关的偏头痛和与月经无关的偏头痛。雌激素替代疗法开始的年龄似乎与中风风险有关。与未使用雌激素替代疗法的女性相比,低剂量(50微克或更低)经皮雌激素替代疗法的女性中风发生率没有增加。童年期受虐待在偏头痛合并抑郁症的女性中比仅患偏头痛的女性更常见。
激素性偏头痛的管理需要明确识别偏头痛与激素变化之间的关系。详细的病史和日记对于识别这种关系以及预测对激素治疗的反应或跟踪反应至关重要。个体偏头痛的演变可能受到激素变化的强烈驱动。虽然证据有限,但临床研究表明,患有发作性偏头痛的年轻女性使用口服避孕药可能会使其发作模式转变为慢性偏头痛。因此,特别关注内源性或外源性激素变化后偏头痛模式的改变至关重要。给予偏头痛是一种生物紊乱的保证和教育,并理解雌激素在偏头痛频率和严重程度中的作用,可以指导治疗选择。药物治疗包括急性治疗,在适当情况下提供短期和标准预防措施。激素治疗不是一线治疗,但对于雌激素波动不断加剧偏头痛发作的偏头痛女性可能是重要的选择。鉴于偏头痛女性一生中会经历多个激素阶段,治疗可能会根据激素阶段和状态而有所不同。还应强调整体健康;定期锻炼、均衡饮食、戒烟、控制体重和保持良好的睡眠卫生对偏头痛的管理很重要。